CareDx unveils personalized patient monitoring solution – AlloHome

CareDx, Inc., a well-known precision medicine solutions provider, has reportedly announced the availability of its pan-organ patient monitoring solution, AlloHome™, for extended care in patients’ homes. The novel solution will capture a range of vital health data to help doctors with the early detection of adverse clinical events, to subsequently make preemptive measures for avoiding complications in pre- and post-transplantation.

Apparently, the biometric results collected using the AlloHome devices via a fully integrated system will flow seamlessly into the AlloCare app without any manual entry. The readings of this real-time data will then be transmitted to skilled CareDx transplant professionals for escalating the potential concerns to the patient’s doctors on time.

For the uninitiated, the regular monitoring of evaluative patient health data with the help of AlloHome will enhance the continuity of care, while offering the edge for earlier interventions to limit readmission and upgrade patient engagement at each step along the transplant journey.

CEO and President of CareDx, Reg Seeto, shed light on CareDx’s commitment to accelerating innovative digital health solutions to support patients at all stages in their transplant journey and expressed pride in delivering the new convenient patient monitoring offering for augmented care.

Meanwhile, MD & Surgical Director of Abdominal Transplant Surgery at Medical City Dallas Hospital, Matthew Mulloy, stated that AlloHome remote monitoring would be extremely beneficial in pushing earlier interventions by receiving notifications when patients show signs of potential problems.

Matthew further claimed that access to real-time data will help in making more informed as well as timely decisions regarding the patient’s care for improving outcomes and reducing the incidence of severe complications and hospital readmission.

It is also worth noting that AlloHome will offer personalized and real-time monitoring for ensuring that all patients, inclusive of the underserved communities, that face difficulties in accessing healthcare will now receive high-quality continuous care and oversight to meet their condition.


Source Credits:–and-Post-Transplant-Care

Back to top button